Pomalidomide 4 mg Tablet Exporter | Vision Pharma – Global Pharmaceutical Supplier
Pomalidomide 4 mg Tablet: An Educational Overview
Pomalidomide 4 mg Tablet contains pomalidomide, an immunomodulatory medicine used in the treatment of certain blood cancers. It is primarily used in adults with multiple myeloma in specific treatment settings, generally when the disease has progressed after previous therapies.
Pomalidomide is a prescription medicine and should only be used under the supervision of a qualified healthcare professional.
Product Overview
Product Name: Pomalidomide 4 mg Tablet
Active Ingredient: Pomalidomide
Strength: 4 mg
Dosage Form: Tablet
Therapeutic Category: Antineoplastic / Immunomodulatory Agent
Primary Medical Use: Certain treatment regimens for multiple myeloma
The appropriate dose and treatment schedule depend on the patient's medical history, previous treatments, blood counts, kidney and liver function, and the overall treatment plan prescribed by an oncologist.
How Pomalidomide Works
Pomalidomide belongs to the immunomodulatory drug class. It can affect the activity of the immune system and interfere with processes that support the growth and survival of certain cancer cells.
Because its effects can be significant, treatment requires appropriate medical monitoring, including laboratory testing when recommended by the treating healthcare team.
Important Safety Information
Pomalidomide is a potent prescription medicine with important safety restrictions. It can cause serious harm to an unborn baby and must be handled according to applicable pregnancy-prevention and medication-safety requirements.
Other important risks may include:
Low blood cell counts
Increased risk of infections
Blood clots
Fatigue and weakness
Dizziness
Gastrointestinal effects
Other treatment-related adverse effects
Patients should follow their oncologist's instructions carefully and report concerning symptoms promptly.
Global Healthcare Context
Pomalidomide is used within specialist oncology care in many international healthcare markets. Availability, prescribing requirements, registration status, and dispensing rules can differ substantially between countries.
Healthcare professionals should verify the applicable regulatory requirements and approved indications in their jurisdiction before prescribing or dispensing this medicine.
Frequently Asked Questions
Q1. What is Pomalidomide 4 mg Tablet used for?
Pomalidomide is an immunomodulatory medicine used in specific treatment regimens for certain patients with multiple myeloma.
Q2. Is Pomalidomide 4 mg a prescription medicine?
Yes. Pomalidomide is a prescription medicine requiring specialist medical supervision.
Q3. Who determines the appropriate Pomalidomide dose?
The treating oncologist determines the dose and treatment schedule based on the patient's condition, previous therapy, laboratory results, and other clinical factors.
Q4. Can Pomalidomide be used during pregnancy?
Pomalidomide can cause serious fetal harm and is subject to strict pregnancy-prevention precautions. Patients should discuss pregnancy-related considerations with their healthcare professional before treatment.
Q5. Does Pomalidomide require medical monitoring?
Yes. Blood counts and other clinical factors may need monitoring throughout treatment.
Q6. Can Pomalidomide be combined with other medicines?
It may be prescribed as part of a combination treatment regimen, but the specific medicines and doses must be determined by the treating oncology team.
Related Information
For authoritative information about pomalidomide, patients and healthcare professionals should consult the prescribing information approved by the relevant national medicines regulator and discuss treatment decisions with a qualified oncology professional.